Biofarm (BSE:BIO) Short Interest


BSE:BIO Biofarm SA BSE:BIO
69 GF Score
Price lei1.37
GF Value lei0.87
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biofarm Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BSE:BIO vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofarm Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Short Interest distribution charts can be found below:

* The bar in red indicates where Biofarm's Short Interest falls into.


BSE:BIO
69GF Score
Biofarm SA BSE:BIO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biofarm (BSE:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biofarm stock appears to be overvalued. The current stock price of lei1.37 is trading 57.5% above its estimated GF Value™ of lei0.87. GuruFocus considers Biofarm to be Significantly Overvalued.

Key valuation signals for BSE:BIO:

  • Short Interest:
  • GF Value™: lei0.87 vs. price of lei1.37 (57.5% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the BSE:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofarm Business Description

Address 99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
69GF Score

Get the complete analysis for BSE:BIO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei1.37
Price
lei0.87
GF Value